BACKGROUND. Heparin is an effective, widely used treatment for unstable angina. Among patients enrolled in a double-blind, randomized, placebo-controlled trial comparing intravenous heparin, aspirin, both treatments, and neither during the acute phase of unstable angina, we encountered patients in whom unstable angina was reactivated after heparin was discontinued. METHODS. The study population included 403 of the original 479 patients in the trial who had completed six days of blinded therapy without refractory angina or myocardial infarction. After the discontinuation of therapy, clinical events, including reactivation of unstable angina and myocardial infarction occurring within 96 hours after hospitalization, were closely monitored. RESULTS. Early reactivation occurred in 14 of the 107 patients who received heparin alone, as compared with only 5 patients in each of the other three study groups (P less than 0.01). These reactivations required urgent intervention (thrombolysis, angioplasty, or coronary-bypass surgery) in 11 patients treated with heparin alone, but in only 2 patients in the other groups combined (P less than 0.01). Four of the six patients who had a myocardial infarction during a reactivation of their disease were in the heparin group. Reactivations in this group occurred in a cluster a mean (+/- SD) of 9.5 +/- 5 hours after the discontinuation of the study drug but were randomly distributed over the initial 96 hours in the other three groups. CONCLUSIONS. Although heparin is beneficial in treating unstable angina, the disease process may be reactivated within hours of the discontinuation of this drug. Concomitant therapy with aspirin may prevent this withdrawal phenomenon.
Source Information
Montreal Heart Institute, QC, Canada.
This article has been cited by other articles:
Newsome, L. T., Weller, R. S., Gerancher, J. C., Kutcher, M. A., Royster, R. L.
(2008). Coronary Artery Stents: II. Perioperative Considerations and Management. Anesth. Analg.
107: 570-590
[Abstract][Full Text]
Goodman, S. G., Menon, V., Cannon, C. P., Steg, G., Ohman, E. M., Harrington, R. A.
(2008). Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 708S-775S
[Abstract][Full Text]
Ho, P. M., Peterson, E. D., Wang, L., Magid, D. J., Fihn, S. D., Larsen, G. C., Jesse, R. A., Rumsfeld, J. S.
(2008). Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome. JAMA
299: 532-539
[Abstract][Full Text]
Oie, C. I., Olsen, R., Smedsrod, B., Hansen, J.-B.
(2008). Liver sinusoidal endothelial cells are the principal site for elimination of unfractionated heparin from the circulation. Am. J. Physiol. Gastrointest. Liver Physiol.
294: G520-G528
[Abstract][Full Text]
American College of Cardiology/American Heart Asso, , Developed in Collaboration With the Canadian Cardi, , Endorsed by the American Academy of Family Physici, , 2007 Writing Group to Review New Evidence and Upda, , Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., Pearle, D. L., Sloan, M. A., Smith, S. C. JR
(2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. J Am Coll Cardiol
51: 210-247
[Full Text]
Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, 2004 Writing Committee Members, , Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., Mullany, C. J., Ornato, J. P., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W.
(2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation
117: 296-329
[Full Text]
Levi, M., Levy, M., Williams, M. D., Douglas, I., Artigas, A., Antonelli, M., Wyncoll, D., Janes, J., Booth, F. V., Wang, D., Sundin, D. P., Macias, W. L., for the Xigris and Prophylactic HepaRin Evaluation,
(2007). Prophylactic Heparin in Patients with Severe Sepsis Treated with Drotrecogin Alfa (Activated). Am. J. Respir. Crit. Care Med.
176: 483-490
[Abstract][Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: e1-e157
[Full Text]
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: 652-726
[Full Text]
Schneider, D. J., Sobel, B. E.
(2007). Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs. Circulation
116: 305-315
[Full Text]
Dent, H., Lekic, Z., Vicenzi, M.
(2006). Unfractionated heparin and coronary artery stenting.. Br J Anaesth
97: 582-582
[Full Text]
Ranjbaran, H., Wang, Y., Manes, T. D., Yakimov, A. O., Akhtar, S., Kluger, M. S., Pober, J. S., Tellides, G.
(2006). Heparin Displaces Interferon-{gamma}-Inducible Chemokines (IP-10, I-TAC, and Mig) Sequestered in the Vasculature and Inhibits the Transendothelial Migration and Arterial Recruitment of T Cells. Circulation
114: 1293-1300
[Abstract][Full Text]
Di Nisio, M., Bijsterveld, N. R., Meijers, J. C.M., Levi, M., Buller, H. R., Peters, R. J.G.
(2005). Effects of Clopidogrel on the Rebound Hypercoagulable State After Heparin Discontinuation in Patients With Acute Coronary Syndromes. J Am Coll Cardiol
46: 1582-1583
[Full Text]
Williams, M. S., Ng'alla, L. S.
(2005). Heparin Therapy Leads to Platelet Activation and Prolongation of PFA-100 Closure Time. J CARDIOVASC PHARMACOL THER
10: 273-280
[Abstract]
Sinnaeve, P R, Van de Werf, F J
(2004). Will oral antithrombin agents replace warfarin?. Heart
90: 827-828
[Abstract][Full Text]
Antman, E. M
(2004). The re-emergence of anticoagulation in coronary disease. Eur Heart J Suppl
6: B2-B8
[Abstract][Full Text]
Wallentin, L
(2004). Oral direct thrombin inhibition for anticoagulation in coronary artery disease - focus on the ESTEEM trial. Eur Heart J Suppl
6: B9-B14
[Abstract][Full Text]
Bijsterveld, N. R., Peters, R. J. G., Murphy, S. A., Bernink, P. J. L. M., Tijssen, J. G. P., Cohen, M., TIMI 11B/ESSENCE Study Groups,
(2003). Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: Results from the thrombolysis in myocardial infarction (TIMI) 11B and efficacy and safety of subcutaneous enoxaparin in Non-Q-Wave coronary events (ESSENCE) studies. J Am Coll Cardiol
42: 2083-2089
[Abstract][Full Text]
Tobu, M., Iqbal, O., Messmore, H. L., Ma, Q., Hoppensteadt, D. A., Fareed, J.
(2003). Influence of Different Anticoagulant Agents on Fibrinopeptide A Generation. CLIN APPL THROMB HEMOST
9: 273-292
[Abstract]
Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L.
(2003). American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol
41: 1633-1652
[Full Text]
Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L.
(2003). American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation
107: 1692-1711
[Full Text]
Casserly, I P, Topol, E J
(2003). The primacy of clinical effectiveness for cost effectiveness analysis. Heart
89: 249-250
[Full Text]
Goodman, S. G., Fitchett, D., Armstrong, P. W., Tan, M., Langer, A., for the Integrilin and Enoxaparin Randomized Asses,
(2003). Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide. Circulation
107: 238-244
[Abstract][Full Text]
Jones, H. U., Muhlestein, J. B., Jones, K. W., Bair, T. L., Lavasani, F., Sohrevardi, M., Horne, B. D., Doty, D., Lappe, D. L.
(2002). Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports. Circulation
106: I-19-I-22
[Abstract][Full Text]
Kottke-Marchant, K., Bahit, M.C., Granger, C.B., Zoldhelyi, P., Ardissino, D., Brooks, L., Griffin, J.H., Potthoff, R.F., Van de Werf, F., Califf, R.M., Topol, E.J.
(2002). Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes. Eur Heart J
23: 1202-1212
[Abstract][Full Text]
Husted, S.E., Wallentin, L., Lagerqvist, B., Kontny, F., Stahle, E., Swahn, E.
(2002). Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization. Eur Heart J
23: 1213-1218
[Abstract][Full Text]
Bijsterveld, N. R., Moons, A. H., Meijers, J. C. M., Tijssen, J. G. P., Buller, H. R., Levi, M., Peters, R. J. G.
(2002). Rebound thrombin generation after heparin therapy in unstable angina: A randomized comparison between unfractionated and low-molecular-weight heparin. J Am Coll Cardiol
39: 811-817
[Abstract][Full Text]
Antman, E.M., Cohen, M., McCabe, C., Goodman, S.G., Murphy, S.A., Braunwald, E.
(2002). Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. Eur Heart J
23: 308-314
[Abstract][Full Text]
Lauer, M. A., Houghtaling, P. L., Peterson, J. G., Granger, C. B., Bhatt, D. L., Sapp, S. K., Simoons, M. L., Harrington, R. A., Topol, E. J., Lincoff, A. M.
(2001). Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary Syndromes: Observations From the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial. Circulation
104: 2772-2777
[Abstract][Full Text]
Van Aken, H., Bode, C., Darius, H., Diehm, C., Encke, A., Gulba, D. C., Haas, S., Hacke, W., Puhl, W., Quante, M., Riess, H., Scharf, R., Schellong, S., Schror, K., Schulte, K.-L., Tebbe, U.
(2001). State-of-the-Art Review: Anticoagulation: The Present and Future. CLIN APPL THROMB HEMOST
7: 195-204
[Abstract]
Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V.
(2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Arterioscler. Thromb. Vasc. Bio.
21
: e9-e9
[Full Text]
Turpie, A. G. G., Antman, E. M.
(2001). Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes. Arch Intern Med
161: 1484-1490
[Abstract][Full Text]
Hirsh, J., Anand, S. S., Halperin, J. L., Fuster, V.
(2001). Guide to Anticoagulant Therapy: Heparin : A Statement for Healthcare Professionals From the American Heart Association. Circulation
103: 2994-3018
[Full Text]
Abendschein, D. R., Baum, P. K., Verhallen, P., Eisenberg, P. R., Sullivan, M. E., Light, D. R.
(2001). A Novel Synthetic Inhibitor of Factor Xa Decreases Early Reocclusion and Improves 24-h Patency after Coronary Fibrinolysis in Dogs. J. Pharmacol. Exp. Ther.
296: 567-572
[Abstract][Full Text]
De Lorenzo, F., Noorani, A., Kakkar, V.V.
(2001). Current trends in the management of thromboembolic events. QJM
94: 179-185
[Full Text]
Bahit, M. C., Topol, E. J., Califf, R. M., Armstrong, P. W., Criger, D. A., Hasselblad, V., Betriu, A., Hirsh, J., Ardissino, D., Granger, C. B.
(2001). Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. J Am Coll Cardiol
37: 1001-1007
[Abstract][Full Text]
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., Dalen, J. E.
(2001). Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety. Chest
119: 64S-94S
[Full Text]
Cairns, J. A., Theroux, P., Lewis, H. D. Jr., Ezekowitz, M., Meade, T. W.
(2001). Antithrombotic Agents in Coronary Artery Disease. Chest
119: 228S-252S
[Full Text]
Hebert, D., Lam, J. Y. T.
(2000). Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity. J Am Coll Cardiol
36: 2311-2316
[Abstract][Full Text]
Goodman, S. G., Barr, A., Sobtchouk, A., Cohen, M., Fromell, G. J., Laperriere, L., Hill, C., Langer, A., for the Canadian Efficacy and Safety of Subcutaneo,
(2000). Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol
36: 1507-1513
[Abstract][Full Text]
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., Pepine, C. J., Schaeffer, J. W., Smith, E. E. III, Steward, D. E., Theroux, P., Gibbons, R. J., Alpert, J. S., Eagle, K. A., Faxon, D. P., Fuster, V., Gardner, T. J., Gregoratos, G., Russell, R. O., Smith, S. C. Jr
(2000). ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol
36: 970-1062
[Full Text]
Flather, M.D, Weitz, J.I, Yusuf, S, Pogue, J, Sussex, B, Campeau, J, Gill, J, Schuld, R, Joyner, C.D, Morris, A.L, Lai, C, Theroux, P, Marquis, J.F, Chan, Y.K, Venkatesh, G, Jessel, A
(2000). Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. Eur Heart J
21: 1473-1481
[Abstract]
Merlini, P. A., Ardissino, D., Rosenberg, R. D., Colombi, E., Agricola, P., Oltrona, L., Ottani, F., Galvani, M., Bauer, K. A., Bottasso, B., Bertocchi, F., Mannucci, P. M.
(2000). In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris. Arterioscler. Thromb. Vasc. Bio.
20: 2162-2166
[Abstract][Full Text]
Montalescot, G., Collet, J. P., Lison, L., Choussat, R.e., Ankri, A., Vicaut, E., Perlemuter, K., Philippe, F., Drobinski, G.e., Thomas, D.
(2000). Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol
36: 110-114
[Abstract][Full Text]
Colwell, N. S., Buckley, B. M., Murphy, M. B., Shavelle, D. M., Wuthrich, D. A., Srivathsan, K., Showalter, J. C., Dieter, R. S., Yeghiazarians, Y., Stone, P. H.
(2000). Unstable Angina Pectoris. NEJM
342: 1676-1678
[Full Text]
Abrahamsson, P, Rosengren, A, Dellborg, M
(2000). Improved long-term prognosis for patients with unstable coronary syndromes 1988-1995. Eur Heart J
21: 533-539
[Abstract]
Awtry, E. H., Loscalzo, J.
(2000). Aspirin. Circulation
101: 1206-1218
[Full Text]
Ambrose, J. A., Dangas, G.
(2000). Unstable Angina: Current Concepts of Pathogenesis and Treatment. Arch Intern Med
160: 25-37
[Abstract][Full Text]
Mak, K.-H., Neumann, F.-J., Blasini, M. R., Schmitt, M. C., Alt, M. E., Dirschinger, M. J., Gawaz, M. M., Kastrati, M. A., Schomig, M. A.
(1999). Recovery of Coronary Flow and Left Ventricular Function After Abciximab • Response. Circulation
100
: e110-e110
[Full Text]
Oldgren, J., Linder, R., Grip, L., Siegbahn, A., Wallentin, L.
(1999). Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease. Eur Heart J
20: 1657-1666
[Abstract]
Wallentin, L.
(1999). New trials of LMW heparins -- light and heavy weight as good on short but what about longer distances?. Eur Heart J
20: 1522-1524
The Frax.I.S. Study Group,
(1999). Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). Eur Heart J
20: 1553-1562
[Abstract]
Armstrong, P. W.
(1999). Pursuing Progress in Acute Coronary Syndromes. Circulation
100: 1586-1589
[Full Text]
Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G. G., Bernink, P. J. L. M., Salein, D., Bayes de Luna, A., Fox, K., Lablanche, J.-M., Radley, D., Premmereur, J., Braunwald, E.
(1999). Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non-Q-Wave Myocardial Infarction : Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B Trial. Circulation
100: 1593-1601
[Abstract][Full Text]
Antman, E. M., Cohen, M., Radley, D., McCabe, C., Rush, J., Premmereur, J., Braunwald, E.
(1999). Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non-Q-Wave Myocardial Infarction : TIMI 11B-ESSENCE Meta-Analysis. Circulation
100: 1602-1608
[Abstract][Full Text]
Becker, R. C., Spencer, F. A., Li, Y., Ball, S. P., Ma, Y., Hurley, T., Hebert, J.
(1999). Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes: Potential mechanisms for heightened prothrombotic potential. J Am Coll Cardiol
34: 1020-1027
[Abstract][Full Text]
Zed, P. J., Tisdale, J. E., Borzak, S.
(1999). Low-Molecular-Weight Heparins in the Management of Acute Coronary Syndromes. Arch Intern Med
159: 1849-1857
[Abstract][Full Text]
Matthai, W. H. Jr., Kurnik, P. B., Groh, W. C., Untereker, W. J., Siegel, J. E.
(1999). Antithrombin activity during the period of percutaneous coronary revascularization: Relation to heparin use, thrombotic complications and restenosis. J Am Coll Cardiol
33: 1248-1256
[Abstract][Full Text]
Frostfeldt, G., Ahlberg, G., Gustafsson, G., Helmius, G., Lindahl, B., Nygren, A., Siegbahn, A., Swahn, E., Venge, P., Wallentin, L.
(1999). Low molecular weight heparin (dalteparin) as adjuvant treatment to thrombolysis in acute myocardial infarction--a pilot study: Biochemical Markers in Acute Coronary Syndromes (BIOMACS II). J Am Coll Cardiol
33: 627-633
[Abstract][Full Text]
Weitz, J. I., Young, E., Johnston, M., Stafford, A. R., Fredenburgh, J. C., Hirsh, J.
(1999). Vasoflux, a New Anticoagulant With a Novel Mechanism of Action. Circulation
99: 682-689
[Abstract][Full Text]
Zaacks, S. M., Liebson, P. R., Calvin, J. E., Parrillo, J. E., Klein, L. W.
(1999). Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?. J Am Coll Cardiol
33: 107-118
[Abstract][Full Text]
Baughman, R. A., Kapoor, S. C., Agarwal, R. K., Kisicki, J., Catella-Lawson, F., FitzGerald, G. A.
(1998). Oral Delivery of Anticoagulant Doses of Heparin : A Randomized, Double-Blind, Controlled Study in Humans. Circulation
98: 1610-1615
[Abstract][Full Text]
Anand, S. S., Yusuf, S., Pogue, J., Weitz, J. I., Flather, M.
(1998). Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction : Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study Results. Circulation
98: 1064-1070
[Abstract][Full Text]
The Platelet Receptor Inhibition in Ischemic Syndr,
(1998). A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina. NEJM
338: 1498-1505
[Abstract][Full Text]
Theroux, P., Fuster, V.
(1998). Acute Coronary Syndromes : Unstable Angina and Non–Q-Wave Myocardial Infarction. Circulation
97: 1195-1206
[Full Text]
Ghigliotti, G., Waissbluth, A. R., Speidel, C., Abendschein, D. R., Eisenberg, P. R.
(1998). Prolonged Activation of Prothrombin on the Vascular Wall After Arterial Injury. Arterioscler. Thromb. Vasc. Bio.
18: 250-257
[Abstract][Full Text]
Xiao, Z., Theroux, P.
(1998). Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor. Circulation
97: 251-256
[Abstract][Full Text]
Altman, R.
(1998). Controversies in Antithrombotic Therapy in Cardiovascular Diseases. CLIN APPL THROMB HEMOST
4: 11-24
[Abstract]
Naqvi, T. Z., Shah, P. K., Ivey, P. A., Molloy, M. D., Linn, P., Linker-Israeli, M., Cercek, B., Kaul, S.
(1998). Therapeutic Concentrations of Heparin Augment Platelet Activation at the Time of Coronary Angiography. J CARDIOVASC PHARMACOL THER
3: 91-101
[Abstract]
Olausson, K., Magnusdottir, H., Lurje, L., Wennerblom, B., Emanuelsson, H., Ricksten, S.-E.
(1997). Anti-Ischemic and Anti-Anginal Effects of Thoracic Epidural Anesthesia Versus Those of Conventional Medical Therapy in the Treatment of Severe Refractory Unstable Angina Pectoris. Circulation
96: 2178-2182
[Abstract][Full Text]
Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G.G., Fromell, G. J., Goodman, S., Langer, A., Califf, R. M., Fox, K. A.A., Premmereur, J., Bigonzi, F., Stephens, J., Weatherley, B., The Efficacy and Safety of Subcutaneous Enoxaparin,
(1997). A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease. NEJM
337: 447-452
[Abstract][Full Text]
Armstrong, P. W.
(1997). Heparin in Acute Coronary Disease -- Requiem for a Heavyweight?. NEJM
337: 492-494
[Full Text]
Owa, M., Origasa, H., Saito, M., Owa, M.
(1997). Predictive Validity of the Braunwald Classification of Unstable Angina for Angiographic Findings, Short-Term Prognoses, and Treatment Selection. ANGIOLOGY
48: 663-671
[Abstract]
Klein, W., Buchwald, A., Hillis, S. E., Monrad, S., Sanz, G., Turpie, A. G. G., van der Meer, J., Olaisson, E., Undeland, S., Ludwig, K.
(1997). Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery Disease : Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation
96: 61-68
[Abstract][Full Text]
Franco Gensini, G., Colella, A., Comeglio, M.
(1997). State-of-the-Art Review: Antiplatelet Agents and Thrombin Inhibitors: Combined Modality Therapy. CLIN APPL THROMB HEMOST
3: 82-85
Schwarz, R. P. JR, Becker, J.-C. P., Brooks, R. L., Hursting, M. J., Joffrion, J. L., Knappenberger, G. D., Kogan, T. P., Kogan, P. W., McKinney, A. A.
(1997). State-of-the-Art Review: The Preclinical and Clinical Pharmacology of Novastan (Argatroban): A Small-Molecule, Direct Thrombin Inhibitor. CLIN APPL THROMB HEMOST
3: 1-15
[Abstract]
Schulman, S. P., Goldschmidt-Clermont, P. J., Topol, E. J., Califf, R. M., Navetta, F. I., Willerson, J. T., Chandra, N. C., Guerci, A. D., Ferguson, J. J., Harrington, R. A., Lincoff, A. M., Yakubov, S. J., Bray, P. F., Bahr, R. D., Wolfe, C. L., Yock, P. G., Anderson, H. V., Nygaard, T. W., Mason, S. J., Effron, M. B., Fatterpacker, A., Raskin, S., Smith, J., Brashears, L., Gottdiener, P., du Mee, C., Kitt, M. M., Gerstenblith, G.
(1996). Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable Angina: A Randomized Multicenter Trial. Circulation
94: 2083-2089
[Abstract][Full Text]
McKenzie, C. R., Abendschein, D. R., Eisenberg, P. R.
(1996). Sustained Inhibition of Whole-Blood Clot Procoagulant Activity by Inhibition of Thrombus-Associated Factor Xa. Arterioscler. Thromb. Vasc. Bio.
16: 1285-1291
[Abstract][Full Text]
Grip, L., Hellekant, C., Herzfeld, I., Malmberg, K., Svane, B., Szamosi, A., Velander, M., Ryden, L.
(1996). Coronary Angioplasty in Patients with Unstable Angina, with Special Reference to Preceding Treatment with Antithrombin III and Heparin. CLIN APPL THROMB HEMOST
2: 107-115
[Abstract]
Granger, C. B., Hirsh, J., Califf, R. M., Col, J., White, H. D., Betriu, A., Woodlief, L. H., Lee, K. L., Bovill, E. G., Simes, R. J., Topol, E. J.
(1996). Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction : Results From the GUSTO-I Trial. Circulation
93: 870-878
[Abstract][Full Text]
Yao, S.-K., Akhtar, S., Scott-Burden, T., Ober, J. C., Golino, P., Buja, L. M., Casscells, W., Willerson, J. T.
(1995). Endogenous and Exogenous Nitric Oxide Protect Against Intracoronary Thrombosis and Reocclusion After Thrombolysis. Circulation
92: 1005-1010
[Abstract][Full Text]
Theroux, P.
(1995). Angiographic and Clinical Progression in Unstable Angina : From Clinical Observations to Clinical Trials. Circulation
91: 2295-2298
[Full Text]
Granger, C. B., Miller, J. M., Bovill, E. G., Gruber, A., Tracy, R. P., Krucoff, M. W., Green, C., Berrios, E., Harrington, R. A., Ohman, E. M., Califf, R. M.
(1995). Rebound Increase in Thrombin Generation and Activity After Cessation of Intravenous Heparin in Patients With Acute Coronary Syndromes. Circulation
91: 1929-1935
[Abstract][Full Text]
Patrono, C.
(1994). Aspirin as an Antiplatelet Drug. NEJM
330: 1287-1294
[Full Text]
